The job cuts continue at Rockville-based Human Genome Sciences as the biotechnology company folds its employees and operations into those of the British drugmaker that bought the firm this summer.
The latest round of cuts targets 97 employees who were notified of the decision last week. The firm also warned that additional reductions would be announced in November and during the next calendar year.
The eliminated positions come from both the science and business sides of the firm.
The “internal restructuring” was disclosed in a letter sent on Oct. 15 to Maryland’s Department of Labor, Licensing and Regulation, which requires firms in the state to disclose large staff cuts as part of the Worker Adjustment and Retraining Notification Act…
Choosen excerpts by JMM from
via The Download: Human Genome Sciences layoffs will continue into next year – The Washington Post.
Job Market Monitor 
Discussion
Trackbacks/Pingbacks
Pingback: Merck / To cut 8,500 jobs | Job Market Monitor - October 1, 2013
Pingback: Teva / The drug company to cut 5,000 jobs | Job Market Monitor - October 10, 2013
Pingback: Layoffs in Pharmaceutical Industry / Due to Productivity Crisis in R&D ? | Job Market Monitor - October 11, 2013